Founder and CEO at Vesiculab Ltd. The company aims to bring innovative solutions to nanoscale research and development. Areas of initial focus are extracellular vesicles (EVs), mRNA-encapsulating lipid nanoparticles (mRNA-LNPs) and viral vectors.

Managing the business development and marketing activities at Everest Biolabs, a Boston, MA-based company focusing on automating and improving outcome of extracellular vesicle isolation.

I provide consultancy services to companies targeting the Extracellular Vesicles, LNPs/Nanomedicines and Gene Therapy markets. These range on assessing the size of a given market by application or geography, to become an active participant to commercialisation strategy, marketing planning and sales activities.

I manage all business operations and staff at NanoFCM Co., Ltd in Nottingham UK, the international arm of the Xiamen, China-based parent company NanoFCM Inc.Additionally, I manage international sales and marketing operations, including participation to international conferences, digital marketing and distributor management for NanoFCM Inc.

As director for Europe, Middle East & Africa (EMEA), I manage all operational aspects, including sales, marketing, recruiting and administration. The direct sales team is supplemented by a network of distributors.Working closely with the CEO, I help to create and implement sales & marketing strategies to deliver consistent revenue growth. With a constantly growing user base in Europe, Izon Science is a valued partner in the scientific research community.

Izon Science is a global leader in advanced nanoparticle characterisation, with the development of instruments based on Tunable Resistive Pulse Sensing (TRPS) technology. http://www.izon.com/trps-technology/ The company's deep involvement in the field of exosome research led to the development of the qEV Size Exclusion Chromatography (SEC) columns in collaboration with the original inventors at AMC Amsterdam. http://www.izon.com/products/qev/Izon Science key market segments are:• Extracellular vesicles / exosomes: Izon science provides standardized and reliable methods of purification and analysis.• Nanomedicines: Driving pharmaceutical regulatory approval towards material-based characterisation rather than through validation of the manufacturing process.• Virology / vaccines: Allowing total viral counting, aggregation & formulation studies.• Diagnostics: aptamer-based biospecific analysis, as well as counting bio-particles at very low concentration. • Nano-Education: Izon Science teams-up with governmental and academic organisations to provide solution for the teaching of nanotechnology to undergraduate students, practically as well as theoretically.

Responsible for sales of advanced analytical instruments to the pharmaceutical industry in Europe.